Sources | Names Used |
---|---|
CTRPv2 | doxorubicin:navitoclax (2:1 mol/mol) |
PharmacoGx | doxorubicin:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ELOVL1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | ZNF628 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | NOL4 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | SYT2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
mRNA | ACVR1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
mRNA | TBC1D10C | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | SLCO4A1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
mRNA | NSL1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | ALG3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
mRNA | THUMPD2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |